Biobanks

Global Biobanks Market to Reach US$143.3 Billion by 2030

The global market for Biobanks estimated at US$91.6 Billion in the year 2024, is expected to reach US$143.3 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Physical / Real, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis period. Growth in the Virtual segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.8 Billion While China is Forecast to Grow at 8.8% CAGR

The Biobanks market in the U.S. is estimated at US$29.8 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$15.1 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Biobanks Market - Key Trends & Drivers Summarized

Biobanks are specialized repositories that collect, store, and manage biological samples such as blood, tissue, DNA, and other bodily fluids for use in research and clinical studies. These samples, along with associated data, are invaluable resources for advancing medical research, understanding diseases, and developing new treatments and diagnostics. Biobanks support a wide range of research areas, including genomics, personalized medicine, epidemiology, and translational research. They provide researchers with access to high-quality, well-characterized specimens that are critical for studying disease mechanisms, identifying biomarkers, and testing new drugs and therapies.

The development and utilization of biobanks have been significantly enhanced by advancements in technology and data management. Modern biobanks employ sophisticated systems for sample collection, processing, storage, and retrieval, ensuring the integrity and traceability of specimens. The integration of high-throughput sequencing, bioinformatics, and data analytics enables the extraction of valuable insights from biobank samples, facilitating breakthroughs in medical research. Moreover, the implementation of standardized protocols and quality control measures ensures the consistency and reproducibility of research findings. Biobanks also play a crucial role in large-scale population studies and longitudinal research, providing a foundation for understanding the genetic, environmental, and lifestyle factors that contribute to health and disease.

The growth in the biobank market is driven by several factors. Firstly, the increasing prevalence of chronic and complex diseases, such as cancer and cardiovascular disorders, is driving the demand for biobanks to support research into new treatments and diagnostics. Secondly, the rise of personalized medicine and precision healthcare is boosting the need for well-characterized biological samples that can be used to develop targeted therapies and interventions. Thirdly, the growing focus on genetic and genomic research is expanding the use of biobank samples for studying the genetic basis of diseases and identifying novel biomarkers. Additionally, advancements in biobanking technologies, including automated storage systems and advanced data management platforms, are enhancing the efficiency and capabilities of biobanks. Lastly, increased funding and collaboration between academic institutions, healthcare organizations, and industry players are supporting the establishment and expansion of biobanks, driving market growth and fostering innovation in biomedical research.

SCOPE OF STUDY:

The report analyzes the Biobanks market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Physical / Real, Virtual); Product (Biobanking Equipment, Biobanking Consumables, Laboratory Information Management Systems); Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Other Applications)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 99 Featured) -

• AMS Biotechnology (Europe) Limited
• Bay Biosciences LLC
• BioIVT & Elevating Science
• BioLifeSolutions Inc.
• Biovault Technical
• CENTOGENE NV
• CTI Biotech
• Cureline, Inc.
• Firalis S.A.
• Hamilton Company
• Merck KGaA
• ProteoGenex, Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• US Biolab Corporation, Inc.
• VWR International LLC

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.